Work Item
ASTM WK74668

New Guide for Bioinks and Biomaterial Inks Used in Bioprinting Tissue-Engineered Medical Products

1. Scope

The scope of the Committee shall be the development of standardized nomenclature and definitions of terms, test methods, recommended practices, guides, specifications and performance standards for medical and surgical materials and devices. The Committee will encourage research in this field and sponsor symposia, workshops and publications to facilitate the development of such standards. The Committee will promote liaison with other ASTM Committees and other organizations with mutual interests.

Keywords

Tissue Engineering; Tissue engineered medical product (TEMP); bioinks; biomaterials; bioprinting; biomaterial inks; extrusion-based; encapsulated cells

Rationale

This work item is being initiated to provide bioinks and biomaterial ink best practices. The need for this standard was expressed in multiple arenas, including but not limited to, the F04.42 subcommittee discussion NOV 2018, Advanced Regenerative Manufacturing Institute's (ARMI) BioFabUSA Standards Working Group in a bioprinting standards discussion held 16 APR 2019, and also exhibited in the Standards Coordinating Body (SCB) Needed Standards Report JAN 2020. This standard guide in an effort toward establishing common best practices for bioink properties and printing parameters to allow product developers to more easily characterize products, reproduce test results, and control product quality.

The title and scope are in draft form and are under development within this ASTM Committee.

Details

Developed by Subcommittee: F04.42

Committee: F04

Staff Manager: Kathleen Chalfin

Work Item Status

Date Initiated: 11-08-2020

Technical Contact: Alexis Garcia

Item: 001

Ballot: F04.42 (22-01)

Status: Negative Votes Need Resolution